How Microfluidic Flow Supports Human-Relevant Drug Discovery

Every drug discovery programme depends on the quality of the evidence behind it

Yet traditional in vitro models often struggle to recreate the dynamic conditions found inside the human body. Without the movement of nutrients, oxygen, signalling molecules and metabolites, important biological responses can be missed.

Microfluidic flow helps bridge that gap.

Watch the animation to see how CN Bio’s recirculating microfluidic technology creates more physiologically relevant environments that support tissue function, enable longer-term studies and generate richer biological insight.

Why Does Microfluidic Flow Matter?

Human tissues don’t exist in static conditions.

In the body, cells are continuously exposed to circulating nutrients, oxygen and biochemical signals. This movement helps maintain tissue health, supports cellular communication and influences how tissues respond to drugs.

Microfluidic flow recreates key aspects of this dynamic environment within an Organ-on-a-chip system, helping researchers gain insight that static models alone may not reveal.

With physiologically relevant flow, researchers can:

• Support long-term tissue function
• Maintain healthier, more representative microtissues
• Monitor responses over extended time periods
• Generate richer datasets from multiple endpoints
• Study biological interactions in a more human-relevant environment

More Than Movement – A Foundation for Human-Relevant Insight

Microfluidic flow is not simply about moving liquid.

It creates the conditions needed to support complex tissue biology, helping researchers investigate questions that are difficult to answer using conventional approaches.

When combined with primary human tissues, flow enables researchers to:

• Explore drug metabolism and toxicity in more detail
• Investigate disease biology and treatment response
• Study communication between connected organs
• Measure clinically relevant biomarkers
• Generate data that can strengthen confidence in development decisions

The result is a deeper understanding of biology before progressing to more expensive downstream studies. By generating human-relevant insight earlier in development, researchers can reduce uncertainty, investigate mechanisms more thoroughly and build stronger evidence for critical decision points.

Built For the Questions Traditional Models Can’t Always Answer

CN Bio’s PhysioMimix® platform combines microfluidic flow with primary human tissues to help researchers explore biology in greater depth.

Applications include:

Insight That Builds Confidence

Drug development is full of critical decisions, such as:

• Which candidate should progress?
• Which risk signals matter?
• How much confidence do you have in the evidence available today?

CN Bio develops human-relevant technologies that help researchers answer complex drug discovery questions and generate evidence they can trust.

By providing earlier insight into human biology, PhysioMimix® helps teams reduce uncertainty, investigate mechanisms more clearly and move forward with greater confidence.

---